Two studies suggest that low-density lipoprotein cholesterol (LDL-C) may not to be the main lipid contributor to atherosclerotic cardiovascular disease…
A randomized, double-blind, placebo-controlled trial in chronic kidney disease (CKD) and type 2 diabetes (T2D) concluded that treatment with finerenone…
A contemporary primary prevention cohort study and a systematic review and meta-analysis showed that older people with elevated LDL cholesterol…
A prospective US study suggests that dietary patterns with a higher proinflammatory potential were associated with higher risk of cardiovascular…
A prospective study suggests that incident cardiovascular disease (CVD) event risk depends on the time course of cumulative prior exposure…
Two studies suggest that reproductive life span and adverse pregnancy outcomes are sex-specific risk factors for atherosclerotic cardiovascular disease (CVD)…
The American Heart Association just issued a scientific statement for drug-induced arrhythmias. Drugs from many therapeutic classes may cause or…
A systematic review suggested that Intensive blood pressure (BP)-lowering treatment decreases risk for orthostatic hypotension (OH). OH, before or in…
An international, investigator-initiated, parallel-group, open, blinded-outcome-assessment trial concluded that early rhythm-control therapy was associated with a lower risk of cardiovascular…
A randomized, controlled, double-blind trial showed that 0.5 mg of colchicine once daily significantly reduced cardiovascular disease (CVD) events in…
This website uses cookies.